Levalbuterol tartrate HFA inhalation (Actavis Pharma, Inc.)


Welcome to the PulseAid listing for the Levalbuterol tartrate HFA inhalation drug offered from Actavis Pharma, Inc.. This Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Actavis Pharma, Inc.
NON-PROPRIETARY NAME: levalbuterol tartrate
SUBSTANCE NAME: LEVALBUTEROL TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: AEROSOL, METERED
MARKETING CATEGORY NAME: NDA AUTHORIZED GENERIC
START MARKETING DATE: 2016-10-01
END MARKETING DATE: 0000-00-00


Levalbuterol tartrate HFA inhalation HUMAN PRESCRIPTION DRUG Details:

Item DescriptionLevalbuterol tartrate HFA inhalation from Actavis Pharma, Inc.
LABELER NAME: Actavis Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 45(ug/1)
START MARKETING DATE: 2016-10-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0591-2927_82bbdb5b-f14d-49d2-80ac-e7779b98a33f
PRODUCT NDC: 0591-2927
APPLICATION NUMBER: NDA021730

Other LEVALBUTEROL TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Actavis Pharma, Inc.Levalbuterol tartrate HFA inhalation
Physicians Total Care, Inc.Xopenex HFA
Preferred Pharmaceuticals Inc.Levalbuterol tartrate HFA inhalation
Proficient Rx LPLevalbuterol tartrate HFA inhalation
Sunovion Pharmaceuticals Inc.Xopenex HFA